Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Insulin pump therapy, also known as continuous subcutaneous ... of safety information but is insufficiently utilized due to the current configuration of the system; the comparable database in ...

This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...

Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps.

Māori and Pacific people with type 1 diabetes are less likely to be current insulin pump users. This means there is a clear risk of workforce shortages causing those who would benefit most from ...

PORTLAND, GA, UNITED STATES, November 5, 2024 /EINPresswire / -- The global Implantable Insulin Pump Market was pegged at $2.67 billion in 2020, and is estimated to reach $6.44 billion by 2030, ...

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

What if these cells could pump out insulin in about 10 minutes ... reactions or other side effects such as hypoglycaemia in patients, which happens for current insulin jabs that use synthetic human ...

This system represents a safer, more convenient alternative to traditional insulin pumps, with the potential ... Advancements and Expansion While the current results are promising, Alladi ...

For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become ...

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.

Bengaluru: Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps. Shares of the medical device maker rose about 2.5% to $251 in ...